Therefore, determining the negative control exerted by the CD38 marker in CD4+ T cell differentiation and the mechanism by which this inhibition impacts the control of tumor cells and bacterial infections is critical in patients with liver cirrhosis. The gene discussed is CD38; the disease is neoplasm.